| Prev Close | 93.72 |
| Open | 93.55 |
| Day Low/High | 84.72 / 93.72 |
| 52 Wk Low/High | 47.92 / 103.29 |
| Volume | 4.49M |
| Avg Volume | 760.10K |
| Exchange | NASDAQ |
| Shares Outstanding | 83.88M |
| Market Cap | 7.81B |
| EPS | -0.70 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
DexCom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Matt Dolan, Senior Director of Corporate Affairs, will present an...
DexCom Launches New Clinic Portal For The DexCom CLARITY® Diabetes Management Solution
New Features Enhance Continuous Glucose Monitoring Data and Insights Sharing Between Physicians and Patients
Jim Cramer's Top Takeaways: Johnson Controls, DexCom
Cramer says Johnson Controls has a number of catalysts going for it starting with its forthcoming split into three companies.
Jim Cramer's 'Mad Money' Recap: Whoever Uses the Internet Best, Wins
The Internet is a beast. If you don't feed it, it will eat you alive, Cramer says.
Watch Out: Barbarians At The Gate For DexCom (DXCM)
Trade-Ideas LLC identified DexCom (DXCM) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
DexCom Announces Upcoming Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences: Steven Pacelli, Executive Vice President, Strategy and Corporate...
DexCom, Inc. Reports Second Quarter 2016 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2016.
FDA Advisory Committee Votes In Favor Of Non-Adjunctive Label For DexCom G5 Mobile CGM System
Conference call scheduled for 8:30AM ET
Barbarian At The Gate: DexCom (DXCM)
Trade-Ideas LLC identified DexCom (DXCM) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
FDA Posts Briefing Documents Ahead Of Advisory Committee Meeting
Dexcom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the US Food and Drug Administration (FDA) published the briefing documents ahead of the July 21,...
Insider Trading Alert - MTSI, DXCM And RMD Traded By Insiders
Stocks with insider trader activity include MTSI, DXCM and RMD
Country Music Star Eric Paslay Partners With Dexcom To Share His Story And Help Others Living With Diabetes
Paslay, Who Has Type 1 Diabetes, Can't Imagine Life Without Continuous Glucose Monitoring
DexCom Schedules Second Quarter 2016 Earnings Release And Conference Call For August 2, 2016 At 4:30 P.m. Eastern Time
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2016 financial results after market close on Tuesday, August 2, 2016.
Dexcom (DXCM) Stock Surges on Revolving Credit Agreement
Dexcom (DXCM) stock is advancing in late-afternoon trading on Monday after reaching a $200 million revolving credit agreement.
Trade-Ideas: DexCom (DXCM) Is Today's Strong On High Relative Volume Stock
Trade-Ideas LLC identified DexCom (DXCM) as a strong on high relative volume candidate
Dexcom To Expand Manufacturing Operations To Greater Phoenix, Arizona
New State of the Art Manufacturing Facility will Help Meet Growing Demand for Continuous Glucose Monitoring Technology
Data Supports Continuous Glucose Monitoring (CGM) To Reduce Need For Self-Monitoring Of Blood Glucose For Type 1 Diabetes
Data Presented at American Diabetes Association Shows Improved Diabetes Management with Customized CGM Settings
Trade-Ideas: DexCom (DXCM) Is Today's "Barbarian At The Gate" Stock
Trade-Ideas LLC identified DexCom (DXCM) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Sohn Picks Revisited: Mixed Results From David Einhorn & Jeffrey Smith
Results on conference picks are split as hedge fund industry contends with criticism.
DexCom Announces Upcoming Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences: Kevin Sayer, President & Chief Executive Officer, will present an...
2016 Sohn Investment Conference Live Blog: Session 2
David Einhorn, Jim Chanos presentations close out 2106's Sohn Investment Conference.
Today's Post-Market Loser: DexCom (DXCM)
Trade-Ideas LLC identified DexCom (DXCM) as a post-market laggard candidate
Dexcom, Inc. Announces Acquisition Of Its Distributor In Germany, Switzerland And Austria
Dexcom, Inc. (NASDAQ:DXCM) announced today that it has entered into a definitive agreement to acquire Nintamed, a distribution company with presence in Germany, Switzerland and Austria.
Insider Trading Alert - DXCM, SSD And UBFO Traded By Insiders
Stocks with insider trader activity include DXCM, SSD and UBFO
DexCom, Inc. Reports First Quarter 2016 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended March 31, 2016.
Insider Trading Alert - DXCM, UBFO And CTXS Traded By Insiders
Stocks with insider trader activity include DXCM, UBFO and CTXS
These 5 Stocks Look Toxic -- You'd Better Sell Them Now
It's time to unload these toxic stocks from your portfolio.
DexCom Announces Upcoming Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences: Steven Pacelli, Executive Vice President, Strategy and Corporate...
